Cavoatrial shunt in the treatment of suprahepatic vena cava stricture after liver transplantation
Ernesto P. Molmenti, Davinder S. Grover, Paul J. Thuluvath, Hyun S. Kim, Duke E. Cameron, Andreas G. Tzakis, Andrew S. Klein – 30 August 2004
Ernesto P. Molmenti, Davinder S. Grover, Paul J. Thuluvath, Hyun S. Kim, Duke E. Cameron, Andreas G. Tzakis, Andrew S. Klein – 30 August 2004
Isabel Aguilera, Jose M. Sousa, Francisco Gavilán, Angel Bernardos, Ingeborg Wichmann, Antonio Nuñez‐Roldán – 30 August 2004 – A new form of autoimmune hepatitis referred to as de novo, has been reported after liver transplantation during the past 5 years. The features are identical to those of classical autoimmune hepatitis (AIH), but the facts involved in the onset and outcome of this type of graft dysfunction are still unclear.
Matteo Ravaioli, Giorgio Ercolani, Matteo Cescon, Gaetano Vetrone, Claudio Voci, Walter Franco Grigioni, Antonia D'Errico, Giorgio Ballardini, Antonino Cavallari, Gian Luca Grazi – 30 August 2004 – The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our series, comparing two periods: before and after 1996, when we started to apply the Milan criteria. The study population was composed of patients with a preoperative diagnosis of HCC, confirmed by the pathological report and with a survival of >1 year.
Minhua Wang, Yongjun Tan, Robert H. Costa, Ai‐Xuan L. Holterman – 30 August 2004 – Disruption of the enterohepatic bile acid circulation during biliary tract obstruction leads to profound perturbation of the cholesterol and bile acid metabolic pathways. Several families of nuclear receptor proteins have been shown to modulate this critical process by regulating hepatic cholesterol catabolism and bile acid synthesis through the transcriptional control of cholesterol 7‐α hydroxylase (CYP7A1).
Philip N. Newsome, John Tsiaoussis, Steven Masson, Robert Buttery, Cameron Livingston, Ian Ansell, James A. Ross, Tariq Sethi, Peter C. Hayes, John N. Plevris – 30 August 2004 – Hepatocyte transplantation is restricted by the impaired ability of hepatocytes to engraft and survive in the damaged liver. Understanding the mechanisms that control this process will permit the development of strategies to improve engraftment. We studied changes in liver matrix during acute injury and delineated the mechanisms that perturb the successful adhesion and engraftment of hepatocytes.
Yasuhito Tanaka, Izumi Hasegawa, Takanobu Kato, Etsuro Orito, Noboru Hirashima, Subrat K. Acharya, Robert G. Gish, Anna Kramvis, Michael C. Kew, Namiko Yoshihara, Santosh Man Shrestha, Mobin Khan, Yuzo Miyakawa, Masashi Mizokami – 30 August 2004 – There are two subtypes of hepatitis B virus genotype A (HBV/A) and they are provisionally designated Aa (“a” standing for Africa/Asia) and Ae (“e” for Europe). In a case‐control study, 78 HBV/Aa, 78HBV/Ae, and 78HBV/D carriers from several countries were compared.
30 August 2004
Maciej Wojcicki, Elizabeth B. Haagsma, Annette S.H. Gouw, Maarten J.H. Slooff, Robert J. Porte – 30 August 2004 – Congenital absence of the portal vein (CAPV) is a very rare venous malformation in which mesenteric venous blood drains directly into the systemic circulation. There is no portal perfusion of the liver and no portal hypertension. This abnormality is usually coincidentally discovered in children, the majority of whom have no signs of encephalopathy and only slightly abnormal liver function tests.
Antonio Siniscalchi, Bruno Begliomini, Lesley De Pietri, Vanessa Braglia, Matteo Gazzi, Michele Masetti, Fabrizio Di Benedetto, Antonio D. Pinna, Charles M. Miller, Alberto Pasetto – 30 August 2004 – The risks and benefits of adult‐to‐adult living donor liver transplantation need to be carefully evaluated. Anesthetic management includes postoperative epidural pain relief; however, even patients with a normal preoperative coagulation profile may suffer transient postoperative coagulation derangement.
Mark W. Russo – 30 August 2004